Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 10, 2023
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
Tue, May 9, 2023
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
Joseph Pantginis Reiterated (APTO) at Strong Buy and Held Target at $180 on, May 9th, 2023
Joseph Pantginis of HC Wainwright & Co., Reiterated "Aptose Biosciences Inc." (APTO) at Strong Buy and Held Target at $180 on, May 9th, 2023.
Joseph has made no other calls on APTO in the last 4 months.
There is 1 other peer that has a rating on APTO. Out of the 1 peers that are also analyzing APTO, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Carey Macrury of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $120 on, Monday, March 27th, 2023
